Previous 10 | Next 10 |
Seth Klarman’s 13F portfolio value decreased from $12.56B to $12.33B this quarter. Baupost Group increased Micron Technology and Facebook while dropping Fox Corp. The portfolio continues to be heavily concentrated with the top three positions accounting for ~32% of the 13F ...
Image source: The Motley Fool. Theravance Biopharma, inc (NASDAQ: TBPH) Q2 2021 Earnings Call Aug 3, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Theravance Biopharma, inc (TBPH) Q2 2021 Earnings Call Transcript ...
Theravance Biopharma, Inc. (TBPH) Q2 2021 Earnings Conference Call August 03, 2021 05:00 PM ET Company Participants Gail Cohen - Vice President, Corporate Communications Rick Winningham - Chief Executive Officer Rick Graham - Senior Vice President, Development Frank Pasqualone - Chief Busines...
Theravance Biopharma (TBPH -1.4%) will have top-line results available for two key candidates later this quarter. The company is expecting phase 2b results for izencitinib, an oral pan-Janus kinase ("JAK") inhibitor for ulcerative colitis, and phase 3 results for ampreloxetine, a norepinephri...
Theravance Biopharma (NASDAQ:TBPH): Q2 GAAP EPS of -$0.80. Revenue of $12.91M (-13.9% Y/Y) Press Release For further details see: Theravance Biopharma reports Q2 results
Theravance Biopharma, Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update - Company reiterates Q3 2021 top-line results timing for ampreloxetine Phase 3 and izencitinib Phase 2b in ulcerative colitis - Company's implied 35% share of YUPELRI® ...
Theravance Biopharma to Report Second Quarter 2021 Financial Results on August 3, 2021 PR Newswire DUBLIN, Ireland , July 20, 2021 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the dis...
JuSun/iStock via Getty Images During the week ended June 25, 2021, Healthcare sector rose 2.01% and Healthcare Select Sector SPDR ETF (XLV) gained 1.58% compared to weekly gain of 2.82% of S&P 500 ETF. Leading the top gainers pack was Atossa Therapeutics (ATO...
Gainers: Osmotica Pharmaceuticals (OSMT) +38%, Star Equity (STRR) +16%, Atossa Therapeutics (ATOS) +15%, Vor Biopharma (VOR) +12%, Rezolute (RZLT) +10%.Losers: Theravance Biopharma (TBPH) -8%, Corbus Pharmaceuticals (CRBP) -8%, Kaleido Bi...
primeimages/E+ via Getty Images Richard Branson's Virgin Galactic (SPCE) secured liftoff before the bell on Friday. Shares posted a dramatic advance on regulatory approval for its launch license. Used car dealer CarMax (KMX) rallied in Friday's pre-market as well, boosted by a strong ear...
News, Short Squeeze, Breakout and More Instantly...
Theravance Biopharma Inc. Company Name:
TBPH Stock Symbol:
NASDAQ Market:
Theravance Biopharma Inc. Website:
Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024 PR Newswire DUBLIN , July 22, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its second quarter 2024 financial results and provide a business update...
2024-06-15 00:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update PR Newswire Q1 2024 YUPELRI ® (revefenacin) net sales of $55.2 million , recognized by Viatris, increased 18% from Q1 2023 1 Viatris collaboratio...